Tuberculosis Trial, Recruiting (NCT06971952)

Tuberculosis Trial, Recruiting NCT06971952 Sponsor: University of Virginia Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT06971952 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with drug-sensitive pulmonary tuberculosis (a type of TB affecting the lungs that responds to standard TB medicines) and who have started TB treatment within the last 2 months
People who live within the area served by Haydom Lutheran Hospital
People who plan to receive their TB care at one of the participating study locations
People who are able and willing to give their formal agreement to take part — or, if the person with TB is under 18, their parent or guardian must be able and willing to give consent on their behalf, and the head of the household must also agree if that is a different person

Who may not be able to join:

People who are not able to give formal consent to participate (or provide assent where required)
People who live outside the catchment area of the study sites, or who are receiving their TB care outside that area
Households where all members have already completed TB screening as part of this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tania Thomas, MD MPH, University of Virginia

Phone: 434.297.9460

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06971952

Sponsor: University of Virginia

Phase: Not Applicable

Status: Recruiting

Condition: Tuberculosis

Trial contact: 434.297.9460

More information: https://clinicaltrials.gov/study/NCT06971952

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with drug-sensitive pulmonary tuberculosis (a type of TB affecting the lungs that responds to standard TB medicines) and who have started TB treatment within the last 2 months
People who live within the area served by Haydom Lutheran Hospital
People who plan to receive their TB care at one of the participating study locations
People who are able and willing to give their formal agreement to take part — or, if the person with TB is under 18, their parent or guardian must be able and willing to give consent on their behalf, and the head of the household must also agree if that is a different person

Who may not be able to join:

People who are not able to give formal consent to participate (or provide assent where required)
People who live outside the catchment area of the study sites, or who are receiving their TB care outside that area
Households where all members have already completed TB screening as part of this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Virginia

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

1 September 2028

Where this trial is recruiting

Tanzania

Primary endpoints

TB screening completion for all HHCs before the study-initiated home visit; Quantify the effect of undernutrition severity on the progression to active TB disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov